Trademarkia Logo

Australia

AU$
Trademark Search
CX

View On IPO.GOV.AU

CX
Protected: Registered/protected

Last updated on 23 May 2022

Owner Info

CytomX Therapeutics, Inc.

151 Oyster Point Blvd,

Suite 400, UNITED STATES OF AMERICA

Serial Number

1910400 filed on 12 Dec 2017

Correspondent

Stephanie K. Wade

Sughrue Mion, PLLC,,

2000 Pennsylvania Ave. NW.,

UNITED STATES OF AMERICA

CX

Classification Information

Class [005]
Biological drugs for use in treating cancer, and autoimmunity; therapeutic and medical diagnostic agents and preparations for use in therapies and dia Read More

Mark Details

Serial Number

1910400

Registered On

12 Dec 2017

Renewal On

12 Dec 2027

Mark Type

FIGURATIVE

Legal History

Show more

Status DateAction Taken
23rd May 2022IP Right Goods and Services Items updated
23rd May 2022IP right goods and service classes updated
5th Mar 2020Amendment to International Registration Contact Requested
15th Nov 2018International Registration - Change Received
4th Oct 2018IP Right Registration Published
27th Sept 2018Register Trade Mark
27th Sept 2018Application Status
19th Jul 2018IP Right Acceptance Published
10th Jul 2018Clear Examination report approved
10th Jul 2018User Created Notice correspondence sent